Company Performance Metrics
As of May 18, 2012, XenneX, Inc. was acquired by LifeMap Sciences, Inc. XenneX, Inc. provides services and tools for bio-medical research. The company’s products include GeneCards, a searchable, integrated database of human genes that provides concise genomic related information on all known and predicted human genes. Its GeneCards Suite comprises
GeneDecks that explore sets of GeneCards genes; GeneALaCart that generates a file of GeneCards annotations for list of genes; GeneLoc that presents an integrated map for each human chromosome based on data integrated by the GeneLoc algorithm; GeneNote, a database of human genes and their expression profiles in healthy tissues; GeneAnnot that provides an annotaion of Affymetrix probe-sets; and GeneTide, an automated system for human transcripts (mRNA and ESTs). The company also offers PanDaTox, a database that aims at identifying genes and intergenic regions that are unclonable in E. coli to aid in the discovery of new antibiotics and biotechnologically beneficial functional genes. It serves biotech and pharmaceutical companies, research institutions, and intellectual property organizations worldwide. The company was founded in 2003 and is based in Cambridge, Massachusetts. It has additional offices in Tel Aviv, Israel; and Hong Kong.
